Abstract:Non-small cell lung cancer (NSCLC) remains the most frequent malignancy worldwide, and lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) represent two major subtypes. LINC00628 has been demonstrated to promote LUAD progression; however, its clinical role in NSCLC remains elusive. The aim of the present study was to analyze the expression of long intergenic non-protein coding RNA 628 (LINC00628) in NSCLC, including in the LUAD and LUSC subtypes. In addition, its roles in NSCLC development and prognosis were also examined. Data from The Cancer Genome Atlas (TCGA) database were first used to assess the expression and prognostic potential in both LUAD and LUSC, then LINC00628 expression in 128 NSCLC tissues was measured using reverse transcription-quantitative PCR. A receiver operating characteristic curve was used to assess the ability of LINC00628 to discriminate between patients with LUAD and LUSC. Kaplan-Meier curves were used to analyze the relationship between LINC00628 expression and the overall survival of patients. Cox regression analysis was used to explore the potential prognostic factors that might be independently associated with NSCLC overall survival. Both in silico and tissue analysis data indicated that the expression of LINC00628 was significantly upregulated in NSCLC tissue compared with matched normal controls (P<0.001). LINC00628 expression levels were also significantly higher in LUAD cases than in patients with LUSC (P<0.001). In addition, LINC00628 could discriminate LUAD from LUSC cases. The expression of LINC00628 was significantly associated with tumor size (P=0.013), histological type (P=0.009), lymph node metastasis (P=0.021) and TNM stage (P=0.008). Survival analysis based on data from both TCGA and patients included in the present study identified an association between LINC00628 and overall survival in LUAD, but this relationship was not observed in LUSC for TCGA data. Cox regression analysis demonstrated that high LINC00628 expression was associated with poor overall survival in patients with LUAD (P=0.001), but not in patients with LUSC (P=0.088). In conclusion, LINC00628 expression was upregulated in NSCLC and associated with patient prognosis. Patients with LUAD had higher LINC00628 expression levels than those with LUSC, and increased LINC00628 served as an independent prognostic factor in LUAD, but not LUSC.

Elevated FUS/TLS Expression is Negatively Associated with E-cadherin Expression and Prognosis of Patients with Non-Small Cell Lung Cancer

Sideroflexin1 As a Novel Tumor Marker Independently Predicts Survival in Lung Adenocarcinoma

Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment

A novel gene signature related to focal adhesions for distinguishing and predicting the prognosis of lung squamous cell carcinoma

Expression of Telomeric Repeat Binding Factor 1 in Non-Small Cell Lung Cancer.

Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma

Enhanced Expression of FGF19 Predicts Poor Prognosis in Patients with Non-Small Cell Lung Cancer

The correlation between expression of ETS-1 and E-cadherin, N-cadherin and Vimentin in non-small cell lung cancer

Overexpression Of Fadd And Bcl-Xs Proteins As Novel Prognostic Biomarkers For Surgically Resected Non-Small Cell Lung Cancer

Prognostic Value of Twist, Snail and E-cadherin Expression in Pathological N0 Non-Small-cell Lung Cancer: a Retrospective Cohort Study.

Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis]

SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 Are Crucial Long Non-Coding RNAs Associated with the Prognosis of Lung Squamous Cell Carcinoma.

Role of FSCN1 in the tumor microenvironment of lung squamous cell carcinoma

LINC00628 is Differentially Expressed Between Lung Adenocarcinoma and Squamous Cell Carcinoma and is Associated with the Prognosis of NSCLC

Prognostic Value of High FoxC2 Expression in Resectable Non-Small Cell Lung Cancer, Alone or in Combination with E-cadherin Expression.

High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients

Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.

High CTSL2 expression predicts poor prognosis in patients with lung adenocarcinoma

The Prognostic Value of TTF-1/NKX2-1 in Lung Squamous Cell Carcinoma

The expression and prognostic significance of FOXC1 in non-small cell lung cancer

Foxq1 Overexpression Influences Poor Prognosis In Non-Small Cell Lung Cancer, Associates With The Phenomenon Of Emt